H.R. 7291

In plain English

GRAS Oversight and Transparency Act This bill requires the Food and Drug Administration (FDA) to establish a board to review determinations made by food manufacturers prior to the year 2000 that certain substances are safe for use in food. Under current law, substances added to food must generally be approved by the FDA. However, substances that are generally recognized as safe (GRAS) by qualified experts are exempt from the FDA's premarket review. Manufacturers are not required to notify the FDA when they designate a substance as GRAS. Under the bill, each food manufacturer must provide the board with a list of pre-2000 GRAS designations attributable to the manufacturer. Manufacturers who do not comply may be subject to specified penalties. The board must review each designation and notify Congress and the FDA of (1) a determination that a substance has not been shown to be safe, and (2) a recommendation that the FDA revoke a GRAS designation. After receiving such a notification, if the FDA decides to revoke the GRAS designation, it must notify the manufacturer and provide them an opportunity to offer evidence of the substance’s safety. The FDA must review its revocation

Congressional Research Service summary from Congress.gov (not yet simplified).

Sponsor and status

Loading from Congress.gov…

How South Carolina voted

No recorded roll-call vote on this bill yet. Most bills never get one.

Who lobbied

Lobbying reports name the bills a client worked on. They don't say which side anyone took.

No lobbying reported on this bill in the reports we have loaded (January 2025 through September 2026). Lobbyists report each quarter, about 20 days after it ends, so any lobbying since October 2026 will be added once those reports are filed.